To Examine the Effect of Horizant (Gabapentin Enacarbil) in Primary Restless Legs Syndrome (RLS) Patients Who Are on Dopaminergic Agents and Exhibiting Augmentation
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2018
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 30 Mar 2018 Planned End Date changed from 1 Feb 2019 to 1 Jun 2019.
- 30 Mar 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Jun 2019.
- 13 Feb 2017 Planned number of patients changed from 20 to 50.